Cancer-Free for Four Years, She Applied for Medigap. The Insurer Wanted One More Year.

Photo of Gerelyn Terzo
By Gerelyn Terzo Published

Quick Read

  • Medigap insurers use lookback periods of two to five years for cancer history, and one insurer denied a four-year cancer survivor for being one year short.

  • After the six-month federal guaranteed-issue window closes at 65, insurers can reject Medigap applicants based on medical history, leaving no out-of-pocket maximum protection.

  • Always secure Medigap approval before dropping Medicare Advantage, or risk being stranded on Original Medicare with uncapped cost-sharing and no supplemental coverage.

  • Many financial professionals are salespeople paid on what they push, not whether you end up wealthier. A fiduciary is the opposite. The SEC legally requires them to put your interests first. Advisor.com's free matching tool pairs you with vetted fiduciaries from major national firms, all in under three minutes. See who you match with today.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cancer-Free for Four Years, She Applied for Medigap. The Insurer Wanted One More Year.

© Lucigerma / Shutterstock.com

A 69-year-old woman finished chemotherapy in mid-2022, rang the bell, and has been cancer-free ever since. This year she considered leaving Medicare Advantage for Original Medicare with a Medigap policy. She expected a routine application. The underwriter asked when she had last received cancer treatment. Four years was not enough under that insurer’s guidelines. It wanted five.

She felt healthy. Her oncologist was pleased. On the Medigap application, she was still one year early.

The Window That Already Closed

Federal law gives a new Medicare enrollee one protected Medigap enrollment period. It lasts six months and begins when the person is at least 65 and enrolled in Part B. During that window, an insurer cannot reject the applicant or charge more because of health problems. Afterward, most states allow medical underwriting unless the applicant qualifies for another guaranteed-issue right.

Once underwriting begins, medical history moves to the center of the application. Insurers may look back at cancer treatment, heart disease, chronic obstructive pulmonary disease, stroke, or diabetes complications. One carrier may examine the previous two years, another three, and another five. A rejection from one does not predict the answer from every company. This insurer’s line happened to be five years since treatment. At four, she did not cross it.

Leaving Advantage Is the Harder Direction

Medicare Advantage and Medigap follow different enrollment rules. A person can join or change an Advantage plan during the appropriate enrollment period without answering health questions. Moving in the other direction is harder. Someone can return to Original Medicare during an enrollment period, but that does not guarantee access to Medigap. Outside a protected window, the supplemental insurer may review the applicant’s medical history before saying yes.

That makes the decision at 65 less reversible than it appears. Medicare Advantage can be left. The Medigap policy someone wants on the other side may not be available. Most important, she should apply for Medigap before completing the move. Leaving Advantage first and learning about the cancer lookback afterward could leave her on Original Medicare without supplemental protection.

What a Medigap Rejection Leaves Exposed

Original Medicare has no annual out-of-pocket maximum. Part A can charge another hospital deductible when a new benefit period begins. Part B generally leaves the patient responsible for 20% of the Medicare-approved amount after the deductible, with no ceiling. Medigap Plan G covers most of those gaps after the Part B deductible. Approval replaces open-ended exposure with a known monthly premium. A denial leaves the patient deciding between remaining in Medicare Advantage or accepting Original Medicare’s uncapped cost-sharing.

For a cancer survivor who wants wider access to specialists or cancer centers, neither choice is casual.

State Law May Offer Another Route

The six-month federal window is only the starting point. State protections vary considerably. New York and Connecticut provide wide year-round access. Massachusetts offers broad enrollment protections, while Maine provides a more limited annual opportunity involving at least Plan A. Other states offer birthday windows, but those usually help people who already own Medigap switch policies. They generally do not create a path from Medicare Advantage into a first Medigap policy.

Federal trial rights can also help someone who tried Medicare Advantage when first eligible and returns to Original Medicare within the first year. Other guaranteed-issue rights can arise when a plan ends, leaves the service area, or undergoes certain major network changes. At 69, the woman in this example may be outside the ordinary trial window. Her state and the reason she is leaving Advantage still matter.

Check the Exit Before Taking It

Before changing coverage, three steps can prevent a Medigap rejection from becoming a much larger problem:

  • Ask several insurers how they word their cancer questions. The date that matters may be the last treatment, surgery, medication, or follow-up, depending on the application.
  • Contact the state insurance department or State Health Insurance Assistance Program (SHIP) to check for guaranteed-issue rights that an agent may have missed.
  • Keep the Medicare Advantage plan in place until Medigap approval and its effective date are confirmed. If this insurer’s fifth-year mark is approaching, put the application date on the calendar without assuming approval is guaranteed.

She was cancer-free in her doctor’s eyes. To one underwriter, she was still a year early. That difference is why Medigap approval belongs before the Medicare Advantage exit, not after.

Contact [email protected] for any questions or corrections.

Photo of Gerelyn Terzo
About the Author Gerelyn Terzo →

Gerelyn Terzo is the author of dividend investing handbook "Dividend Investing Strategies: How to Have Your Cake & Eat It Too." A veteran financial journalist, she covers agri-finance for outlets like Global AgInvesting and the broader stock market and personal finance for 24/7 Wall Street. She began at CNBC and later helped launch Fox Business in New York. Gerelyn currently resides in Woodland Park, Colorado and dabbles in nature photography as a hobby.

Continue Reading

Top Gaining Stocks

NDSN Vol: 1,221,030
COIN Vol: 17,440,212
DE Vol: 3,185,601
CF Vol: 3,293,878
MOS Vol: 12,385,997

Top Losing Stocks

MRNA Vol: 97,681,155
WMT Vol: 83,303,314
CTRA Vol: 73,319,495
ISRG Vol: 3,831,732
CRWD Vol: 8,718,491